Redeye strengthens its positive view of Avensia following a strong Q3, with an EBIT significantly ab...
Redeye retains its positive view of CombinedX following the Q3 report.
An in line report on adj. EBITA and -8% org growth (ABGSCe -7%) Cost reductions bear fruit, adj.
'23e-'25e sales cut by 0-3% On the right path toward cash flow generation EV/ARR 1.
Redeye sees a Q3 report from CombinedX with solid underlying data but higher external costs than exp...
Sales 224m (+1% vs. ABGSC), adj. EBITA 22m (+37% vs.
Maven Wireless Sweden AB publicerade den 27 oktober år 2023 bolagets delårsrapport för det tredje kv...
Consti's net sales in Q3 amounted to EUR 89.9m above our estimates (Evli est.
Solteq’s Q3 was slightly upbeat despite the weak figures and the company remains on track on its tur...
SRV delivered encouraging Q3 results considering the current market conditions.
Raute’s Q3, like its orders, showed twofold developments as margins were relatively high while marke...
Redeye strengthens its positive view of Avensia following a Q3 report showing a substantial margin r...
Enersense’s Q3 revenue topped our estimate, while profitability figures came in below our estimates.
Stark tillväxt i Asien och Nordamerika Arcomas omsättning uppgick till 36 mkr (29 mkr) i Q3, motsvar...
Acceleration i USA Över lag en bra rapport för Q3 som levde upp till våra förväntningar.
Fortsatt god kostnadskontroll ARR uppgick vid utgången av det tredje kvartalet till 17,9 mkr, jämför...
Perioden saknade större order Under det tredje kvartalet steg omsättningen med 38% till 227 mkr (164...
Solid Q3-rapport visar på styrka i fokus på nischprodukter En stark volymutveckling och en god kostn...
Redeye see a Q3 2023 report from Nanologica that came in lower than we had projected in terms of sal...
Vaisala posted Q3 results with net sales slightly below our expectations, yet EBIT was very strong a...
